Hints and tips:
Related Special Reports
...JSR’s chief executive Eric Johnson has consistently stressed that the company had initiated discussions with JIC, saying its backing would help to accelerate both the restructuring of the company as well...
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...Johnson & Johnson has struck a deal to buy medical device maker Shockwave Medical for $13.1bn, as the healthcare giant puts cash to work from the spin-off of its consumer health arm to pursue acquisitions...
...ETFs accounted for 51 per cent of underlying assets at the end of last year, up from 46.7 per cent in early 2022, according to data from Broadridge Financial Solutions, a financial technology company, which...
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...The Financial Times revealed in January that JSR’s American chief executive, Eric Johnson, and the rest of the board had previously rejected an approach from the German group Merck that could have led to...
...The deal comes as pharmaceutical companies gather in San Francisco for an annual industry conference, with GSK rivals Johnson & Johnson, Novartis and Merck announcing acquisitions on Monday....
...The deal comes as pharmaceutical companies are gathered in San Francisco for an annual industry conference this week, with GSK rivals Johnson & Johnson striking a $2bn deal to acquire an oncology biotech...
...software company VMware, which closed in November....
...“I’m very happy that Speaker Johnson and House leaders incorporated my recommendation to extend the ByteDance divestment period from six months to a year,” Cantwell said....
...The Trump administration previously tried to ban TikTok, but the company blocked the move in the courts....
...The Cypriot government allowed stocks to be used to treat cats suffering with another coronavirus in the Mediterranean country, though the company said it was not approved for veterinary treatment and no...
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
...A very high dividend in excess of, say, 6 per cent, is often a red flag that a company is in distress or about to cut its dividend.”...
...The company joins Merck, Bristol Myers Squibb and the lobby group Pharmaceutical Research and Manufacturers of America in challenging the new law....
...Johnson & Johnson joins the Merck, Bristol Myers Squibb and pharmaceutical lobby Pharmaceutical Research and Manufacturers of America in challenging the new law....
Global inflows of $965bn last year was the second highest tally on record
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...The exclusions will also apply to fixed income funds, potentially precipitating a sell-off in the bonds of energy companies....
...I remember when the Supreme Court was just about to overturn the Roe v Wade abortion ruling in 2022. I spoke to the CEO of a large American business....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...The companies are also likely to develop documentaries based on WWE to help widen its appeal, Shapiro said....
...Johnson’s backing and the unanimous vote suggest that the bill will have little trouble passing the House....
...Merck’s lawsuit is the first by a major drug company, but analysts predict others are likely to follow its lead and sue the government ahead of the full implementation of the drug price negotiation elements...
...Johnson & Johnson is a very valuable company, notwithstanding its efforts to convince US federal judges of the contrary....
International Edition